Latest news
Knight Therapeutics Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 00:03:00 GMTKnight Therapeutics (TSX:GUD) Stock Revenue Strength Clashes With Lingering Losses - simplywall.stsimplywall.st · Sat, 08 Aug 2026 01:01:19 GMTKnight Therapeutics Inc (TSX: GUD - FinancialContentFinancialContent · Fri, 07 Aug 2026 20:00:00 GMTKnight Therapeutics Inc (KHTRF) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ... - Yahoo Finance SingaporeYahoo Finance Singapore · Thu, 06 Aug 2026 23:15:22 GMTKnight Therapeutics Q2 2026 Earnings Call Transcript - MarketBeatMarketBeat · Thu, 06 Aug 2026 17:40:27 GMTKnight Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:42:32 GMTEarnings Flash (GUD.TO) Knight Therapeutics Reports Q2 Revenue C$144.2M, vs. FactSet Est of C$126.4M - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:05:42 GMTKnight Therapeutics Reports Second Quarter 2026 Results - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 10:38:17 GMT